5240752025-01-012025-03-315240752025-03-315240752024-03-315240752024-04-012025-03-315240752025-01-012025-03-31in-capmkt:OtherExpenses1Member5240752024-04-012025-03-31in-capmkt:OtherExpenses1Member5240752025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15240752024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15240752025-01-012025-03-31RelatedPartyTransactionDomain15240752024-12-31RelatedPartyTransactionDomain15240752025-03-31RelatedPartyTransactionDomain15240752025-01-012025-03-31RelatedPartyTransactionDomain25240752024-12-31RelatedPartyTransactionDomain25240752025-03-31RelatedPartyTransactionDomain25240752025-01-012025-03-31RelatedPartyTransactionDomain35240752024-12-31RelatedPartyTransactionDomain35240752025-03-31RelatedPartyTransactionDomain35240752025-01-012025-03-31RelatedPartyTransactionDomain45240752024-12-31RelatedPartyTransactionDomain45240752025-03-31RelatedPartyTransactionDomain45240752025-01-012025-03-31RelatedPartyTransactionDomain55240752024-12-31RelatedPartyTransactionDomain55240752025-03-31RelatedPartyTransactionDomain55240752025-01-012025-03-31RelatedPartyTransactionDomain65240752024-12-31RelatedPartyTransactionDomain65240752025-03-31RelatedPartyTransactionDomain65240752025-01-012025-03-31RelatedPartyTransactionDomain75240752024-12-31RelatedPartyTransactionDomain75240752025-03-31RelatedPartyTransactionDomain75240752025-01-012025-03-31RelatedPartyTransactionDomain85240752024-12-31RelatedPartyTransactionDomain85240752025-03-31RelatedPartyTransactionDomain85240752025-01-012025-03-31RelatedPartyTransactionDomain95240752024-12-31RelatedPartyTransactionDomain95240752025-03-31RelatedPartyTransactionDomain95240752025-01-012025-03-31RelatedPartyTransactionDomain105240752024-12-31RelatedPartyTransactionDomain105240752025-03-31RelatedPartyTransactionDomain105240752025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524075ALBERTDAVDNOTLISTEDINE155C01010ALBERT DAVID LIMITEDMain BoardEquity2024-04-012025-03-312025-05-132025-05-06INRLakhsQuarterlyFourth quarterSingle segmentPharmacueticals2025-05-1311:45:002025-05-1316:40:00trueCash Flow IndirectDeclaration of unmodified opiniontruefalseNANAfalsetrue2024-03-14https://www.albertdavidindia.com/policies.phpfalsefalsenil2025-01-012025-03-31AuditedStandalone748933000-51144000697789000208951000185506000-101204000226818000131500018175000276315000815876000-1180870000-11808700017884000-32692000-148080000-1032790000000-103279000-11777000-1150560005707200010-18.1-18.100-18.1-18.12024-04-012025-03-31AuditedStandalone34576800002958070003753487000701505000604624000-143298000109024600041040006968900011743400003501210000252277000025227700059242000210270008026900001720080000000172008000-113500001606580005707200010386776200030.1430.140030.1430.14Other Expenses276315000Other Expenses11743400009771230001731100000107200001850000017953100061960000038094600038714200015736770006390200002422117000273732000417300012773000405000004643300027997280001725600084475000354047900051141560005707200038677620003924834000392483400000002559800025598000587290006319500000147522000100492000342530003413210003755740003293750008054410003029300020606600000104180000000118932200051141560001 The above is an extract of the detailed format of Quarterly/Annual Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. The full format of the Quarterly Annual Financial Results and notes thereto along with the Statutory Auditors Report thereon are available on the Stock Exchanges website www.bseindia.com www.nseindia.com and the Companys website www.albertdavidindia.com. <BR> 2 The above Audited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 13th May 2025. <BR> 3 The Annual Financial Results have been audited by the Statutory Auditors as required under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 <BR> 4 The figures for the quarter ended 31st March, 2025 and 31st March, 2024 are the balancing figures between audited figures in respect of the full financial year and the published figures upto the end of third quarter. <BR> 5 The Board of Directors recommended dividend of Rs 5 per equity share of Rs 10 each for the financial year ended 31st March, 2025. <BR> 6 The Company is engaged in the manufacturing of pharmaceutical products and has only one reportable segment in accordance with Ind AS-108 Operating Segments. <BR> 7 Figures for the previous periods have been regrouped to conform to the figures of the current periods as and when required in limited context of format of financial results and disclosures thereon specified by SEBI.4104000-202899000193580000-3552600017937000-309200091000-151000362850000-266120000696890000-295000-48322000-48961000-15000001160002383000375480000-197953000008796000-26620000-451528000-199251000000851070000-284358000001590400000000283900014855900031003400000000000001662500000000238300033787000002330130000000000079493000010436000247300065481000001103000-5024200026000-50216000543890004173000items that will not be reclassified to profit & loss-16153000-16153000items that will not be reclassified to profit & loss-3860000-3860000-4376000749000000-11777000-11350000Albert David Limited******Gillander Arbuthnot and Company Limited******Company in which KMP/Director has significant influencePurchase of goods or services5000000Not Applicable22450002025-05-13224500000Albert David Limited******Strategic Marketing Solutions & Research Centre Private Limited******Company in which KMP/Director has significant influencePurchase of goods or services3000000Not Applicable21000002025-05-13210000000Albert David Limited******Khaitan & Co. LLP******Company in which KMP/Director has significant influenceAny other transactionLegal charges10000000Not Applicable20380002025-05-13203800000Albert David Limited******Prabhawati Devi Kothari******Non-Executive DirectorAny other transactionSitting fees to Promoter Directors2500000Not Applicable650002025-05-136500000Albert David Limited******Anand Vardhan Kothari******Non-Executive DirectorAny other transactionSitting fees to Promoter Directors2500000Not Applicable250002025-05-132500000Albert David Limited******Kothari Medical Centre******Trust in which KMP has significant influenceAny other transactionDonation paid20000000Not Applicable50000002025-05-13500000000Albert David Limited******Kothari Phytochemicals & Industries Ltd.******Company in which KMP/Director has significant influenceAny other transactionSale of Equity Shares80000000Not Applicable50000002025-05-13500000000Albert David Limited******PDK Family Trust******Company in which KMP/Director has significant influenceAny other transactionSale of Equity Shares80000000Not Applicable20000002025-05-13200000000Albert David Limited******G Das & Co. Pvt.Ltd******Company in which KMP/Director has significant influenceAny other transactionSale of Equity Shares80000000Not Applicable34000002025-05-13340000000Albert David Limited******Mr. Arun Kumar Kothari******Chairman & Executive DirectorRemuneration25000000Not Applicable116940002025-05-13116940000033567000AuditedtrueL B Jha & Co.true2028-01-31